Multiple Sclerosis Agents

Random Miscellaneous Quiz

Can you name the Multiple Sclerosis Agents?

Quiz not verified by Sporcle

How to Play
SE: HR reduction of 10-20 bpm, occasionally bradyarrhythmias or AV block -- screen for cardiac dz (6 hr monitoring w/ first dose). Macular edema in 1% (reversible). Check varicella
Duloxetine class
Second line agent: RRMS. Reduced relapses & progression of disability
Use: Depression. Also helps with fatigue
SE: Localized inj site reactions. Self-limited (15-20 min) acute rxn resembling a panic attack (palpitations, dyspnea, flushing) -- not an indication to stop tx
Bupropion class
MOA: Monoclonal Ab. Shows functional improvement not just slowing of decline
Dose: Oral. In extreme cases intrathecal
Dose: 1 gram/day IV for 3-5 days
Methotrexate class
Cyclophosphamide class
Natalizumab class
MOA: Synthetic form of myelin basic PRO copolymer 1. Binds to MHC molecules. Competes w/ myelin antigens for presentation to T cells.
Daclizumab class
MOA: Purine analog
Baclofen class
Methylphenidate class
Axathioprine class
Mitoxantrone class
Use: Fatigue, cognitive impairment (long acting agent)
Modafinil class
First line drugs for disease modification
Tricyclic class
First line RRMS agent injected SC daily
Dose: 1250 mg/day PO for 3-5 days
Fingolimod class
Second line agent given IV monthy
MOA: Anti-organ rejection drug
SE: Inj site rxn w/ high doses, flu-like s/s (responds well to naproxen), monitor liver fx, may develop neutralizing Ab, may increase depression.
Excreted by kidney: contraindicated in moderate to severe renal failure
Tizanidine class
Dose: IV infusion every 3 months
SE: Seizures at higher than recommended doses (contraindicated in pts with a hx of seizure)
SE: Risk of progressive multifocal leukoencephalopathy. Rare fatal viral (polymyxoma JC virus) reactivation infxn affecting white matter in immunosuppressed (only a risk to pts w/
Carbamazepine class
Second line agent MOA: monoclonal Ab
Use: Fatigue
SE: Thyroid disorders, ITP (with fatal brain hemorrhage), infections.
Mycophenolate class
Gabapentin class
Second line agent: RRMS, SPMS, Progressive Relapsing MS
Dose: SC injection every other day
MOA: Potassium channel blocker. Possibly increases conduction in demyelinated axons
MOA: Sphingosine 1-phosphate receptor modulator. Sequesters lymphocytes.
Prednisone class
MOA: Immune modulator, exact mechanism not known.
Use: For pts who do not respond to corticosteroids during acute attacks
MOA: Antimetabolite and antifolate
Dose: SC injection 2-3 times weekly
Dose: IM weekly
Use: Depression. Also helps with pain
Rituximab class
Off line agent used in the treatment of acute attacks
Glatiramer acetate class
MOA: alkylating agent
Alemtizumab class
IFN beta 1-a (Rebif) class
Use: treatment of spasticity
IFN beta 1-a (Avonex) class
IFN beta 1-b (Betaseron) class
Venlafaxine class
MOA: Immunomodulator/antineoplastic
Methylprednisone class
Use: pain and paroxysmal disorders
Dose: Oral daily (first PO MS drug)
Plasmapheresis class
Dalfampridine class
Second line agent for RRMS that produces reduction in progression of disabilty

Friend Scores

  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...


Created Oct 18, 2011ReportNominate
Tags:agent, multiple